If you have been reading about TB-500 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-08-05. Numbers and descriptions here follow the published literature rather than marketing material.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilised powder | Sealed vial; reconstituted before laboratory use |
| Appearance | White to off-white solid | Visual descriptor used on certificates of analysis |
| Solubility class | Water-soluble | Dissolves in water and aqueous buffers |
| Reported mass, fragment | Near 889 Da | Value depends on the stated sequence |
| Reported mass, parent protein | Near 4963 Da | 43-residue thymosin beta-4 |
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
== Transmutation of technetium to stable ruthenium-100 == Technetium (Tc) can be completely transformed into ruthenium-100 by coating the inner cladding of fuel rods with Tc. This works with conventional pressurized water reactors and does not require specialized transmutation facilities. An alternative disposal method, transmutation, has been demonstrated at CERN and NIIAR for technetium-99. This transmutation process bombards the technetium (99Tc as a metal target) with neutrons, forming the short-lived 100Tc (half-life 16 seconds), which decays by beta decay to stable ruthenium (100Ru). Given the relatively high market value of ruthenium and the particularly undesirable properties of technetium, this type of nuclear transmutation appears particularly promising.
== Development in humans == Newborn humans are not developed enough yet to chew and thus cannot handle eating solids, and survive solely on drinking liquid breast milk or infant formula. As infant development proceeds, small amounts of puréed baby foods are sometimes fed to babies as young as two or three months old, but most infants do not eat anything solid until they are between six and eight months old. Premastication, in which adults chew up food and then "kiss-feed" a softened food bolus into the infant's mouth, can also be seen in many undeveloped countries as a form of improvised puréed food. The practices of feeding only liquid or semi-liquid food to young infants is because they still have few teeth and an immature digestive system. Between 8 and 12 months of age, the digestive system improves and deciduous teeth progressively emerge (i.e. "teething"), and many babies can begin weaning and eating finger foods. Their diet is still limited, however, because most babies lack molars or canines at this age, and often have a limited number of incisors. By 18 months, babies often have enough teeth and a sufficiently mature digestive system to eat the same foods as adults. Learning to eat food is a messy process for children, and they often do not master neatness or eating etiquette until five or six years old.
Bully: Brett Height: 5'8 Weight: 164 lb Victim(s): Zack Fighter: Abel Cullum Height: 5'7 Weight: 158 lb Money earned by Bully: $1000 Money earned by victim(s): $9000 Original airing: Friday October 4, 2012.
=== Ecology === Under natural conditions Brucella spp, including B. canis are obligate parasites and do not grow outside the host except in laboratory cultures. However, at specific temperatures and moisture levels Brucella can persist in soil and surface water up to 80 days. The bacterium can also survive for months in frozen conditions. B. canis is mainly found in dogs, but can also affect other wild canine species such as wolves, foxes, and coyotes. The bacterium persists in these hosts, being an adaptive pathogen towards canines. The environment these hosts reside in further contribute to the canine specificity. Dog kennels are a favored environment for the bacterium to spread due to transmission through urine and reproductive fluids. Movement of infected animals through pet trade or shelter transport also plays a critical role in the broader distribution of the bacterium. In wildlife, B. canis is also circulated through hunting and scavenging. Zoonotic transmission to humans is rare but possible, particularly for people in close contact with infected reproductive tissues. Certain occupations are at higher risk of exposure to B. canis. These persons include veterinarians, kennel workers, dog breeders, and laboratory personnel.
Sources: en.wikipedia.org
From the incorporation of Scarborough as a township in 1850, the head of the local government was a reeve who chaired the town council. In 1953, Scarborough and twelve other townships, towns, and villages in York County federated with the City of Toronto to form Metropolitan Toronto. Scarborough retained its own town council but an added layer of government, the Metropolitan Toronto Council, with the reeve of Scarborough having a seat. In 1967, Scarborough was incorporated as borough at which point the head of the local government was styled as mayor. A Board of Control, consisting of the mayor and four directly elected Controllers, was also created as an executive committee of Scarborough's council, whose members also sat on Metro Council. In 1973, Scarborough opened its new city hall, the Scarborough Civic Centre where the borough and later its city council met. In 1983, Scarborough attained city status, but its governing structure remained the same. In 1988, the Board of Control was abolished. In 1998, the municipalities of Metropolitan Toronto were dissolved and amalgamated into a single City of Toronto. Since then, Scarborough has been a community within the city of Toronto, and the head of the local government is the Mayor of Toronto and is governed by Toronto City Council. Community councils were formed to process issues considered local to their communities. Scarborough's community council, made up of the district's local councillors, meets once a month at the Civic Centre.
The Kingdom of Hanover maintained an army after the Napoleonic Wars. In 1832, King William IV of Hanover and the United Kingdom issued his troops with British Army uniforms, but they differed slightly from their original British versions. When the personal union with the United Kingdom ended in 1837, and Ernst August ascended to the crown of Hanover, he replaced their uniforms with Prussian Army-style ones, which included the pickelhaube spiked helmet for his Guard Corps. By 1866 they wore a more Austrian style of uniform, with only the guard corps keeping the Prussian one. During the Austro-Prussian War, the Hanoverian Army fought and defeated the Prussians during its march south towards Austria, at the Battle of Langensalza. However, it was later surrounded and forced to surrender to Prussia.
The chemical and thermal dynamics in hydrothermal vents makes such environments highly suitable thermodynamically for chemical evolution processes to take place. Therefore, thermal energy flux is a permanent agent and is hypothesized to have contributed to the evolution of the planet, including prebiotic chemistry. Günter Wächtershäuser proposed the iron-sulfur world theory and suggested that life might have originated at hydrothermal vents. Wächtershäuser proposed that an early form of metabolism predated genetics. By metabolism he meant a cycle of chemical reactions that release energy in a form that can be harnessed by other processes. It has been proposed that amino acid synthesis could have occurred deep in the Earth's crust and that these amino acids were subsequently shot up along with hydrothermal fluids into cooler waters, where lower temperatures and the presence of clay minerals would have fostered the formation of peptides and protocells. This is an attractive hypothesis because of the abundance of CH4 (methane) and NH3 (ammonia) present in hydrothermal vent regions, a condition that was not provided by the Earth's primitive atmosphere. A major limitation to this hypothesis is the lack of stability of organic molecules at high temperatures, but some have suggested that life would have originated outside of the zones of highest temperature. There are numerous species of extremophiles and other organisms currently living immediately around deep-sea vents, suggesting that this is indeed a possible scenario.
Sources: en.wikipedia.org
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.
Naming for research peptides is not standardised, and suppliers sometimes apply the same label to different chain lengths. Certificates of analysis and mass data are the practical way to determine what a given lot contains.
The fragment commonly cited under this label is reported near 889 Da, and the parent protein near 4963 Da. Reported values shift with the exact sequence and with residual counter-ions or water in the sample.
Standard practice is a desiccated container at −20 °C, protected from light and kept sealed between uses. Letting the vial reach room temperature before opening reduces condensation on the powder. Repeated warming and cooling of the whole container is generally avoided.